# Adial Pharmaceuticals, Inc. (AZR)

Source page: https://stoqly.net/companies/azr

- **Ticker:** AZR (Nasdaq)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001513525
- **Latest annual report:** 10-K filed 2026-03-05 (https://www.sec.gov/Archives/edgar/data/1513525/000121390026024175/ea0279150-10k_adial.htm)
- **Data updated:** 2026-11-09

## Key figures

- **Last close:** $3.75 on 2026-11-09 (−6.25% on the day)
- **Market cap:** $17.3M
- **EPS, trailing 12 months:** −$11.53
- **Return on equity:** −170.7%
- **Change in share count:** +244.5%
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/azr/figures.csv

| US$ millions | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Operating income | -1 | -7 | -8 | -11 | -19 | -11 | -7 | -8 | -8 |
| Net income | -1 | -12 | -9 | -11 | -19 | -13 | -5 | -13 | -8 |
| Diluted EPS (US$) | -0.35 | -2.44 | -0.87 | -0.87 | -1.04 | -12.71 | -3.60 | -68.01 | -11.93 |
| Operating cash flow | 0 | -2 | -6 | -8 | -12 | -11 | -7 | -7 | -6 |
| Free cash flow | — | — | — | — | -12 | — | — | — | — |
| Cash | 0 | 4 | 7 | 4 | 6 | 4 | 3 | 4 | 6 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.